Table of Content

1 Plasma Derived Drugs Market Overview
1.1 Product Overview and Scope of Plasma Derived Drugs
1.2 Plasma Derived Drugs Segment by Type
1.2.1 Global Plasma Derived Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Immunoglobulins
1.2.3 Albumins
1.2.4 Clotting Factors
1.2.5 Others
1.3 Plasma Derived Drugs Segment by Application
1.3.1 Plasma Derived Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Global Plasma Derived Drugs Market Size Estimates and Forecasts
1.4.1 Global Plasma Derived Drugs Revenue 2016-2027
1.4.2 Global Plasma Derived Drugs Sales 2016-2027
1.4.3 Plasma Derived Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Plasma Derived Drugs Market Competition by Manufacturers
2.1 Global Plasma Derived Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Plasma Derived Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Plasma Derived Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Plasma Derived Drugs Manufacturing Sites, Area Served, Product Type
2.5 Plasma Derived Drugs Market Competitive Situation and Trends
2.5.1 Plasma Derived Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Plasma Derived Drugs Players Market Share by Revenue
2.5.3 Global Plasma Derived Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Plasma Derived Drugs Retrospective Market Scenario by Region
3.1 Global Plasma Derived Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Plasma Derived Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Plasma Derived Drugs Market Facts & Figures by Country
3.3.1 North America Plasma Derived Drugs Sales by Country
3.3.2 North America Plasma Derived Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Plasma Derived Drugs Market Facts & Figures by Country
3.4.1 Europe Plasma Derived Drugs Sales by Country
3.4.2 Europe Plasma Derived Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Plasma Derived Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Plasma Derived Drugs Sales by Region
3.5.2 Asia Pacific Plasma Derived Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Plasma Derived Drugs Market Facts & Figures by Country
3.6.1 Latin America Plasma Derived Drugs Sales by Country
3.6.2 Latin America Plasma Derived Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Plasma Derived Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Plasma Derived Drugs Sales by Country
3.7.2 Middle East and Africa Plasma Derived Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Plasma Derived Drugs Historic Market Analysis by Type
4.1 Global Plasma Derived Drugs Sales Market Share by Type (2016-2021)
4.2 Global Plasma Derived Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Plasma Derived Drugs Price by Type (2016-2021)

5 Global Plasma Derived Drugs Historic Market Analysis by Application
5.1 Global Plasma Derived Drugs Sales Market Share by Application (2016-2021)
5.2 Global Plasma Derived Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Plasma Derived Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Grifols, S.A.
6.1.1 Grifols, S.A. Corporation Information
6.1.2 Grifols, S.A. Description and Business Overview
6.1.3 Grifols, S.A. Plasma Derived Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Grifols, S.A. Product Portfolio
6.1.5 Grifols, S.A. Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Corporation Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma Plasma Derived Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Octapharma Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 Antares Pharma
6.3.1 Antares Pharma Corporation Information
6.3.2 Antares Pharma Description and Business Overview
6.3.3 Antares Pharma Plasma Derived Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Antares Pharma Product Portfolio
6.3.5 Antares Pharma Recent Developments/Updates
6.4 CSL Limited
6.4.1 CSL Limited Corporation Information
6.4.2 CSL Limited Description and Business Overview
6.4.3 CSL Limited Plasma Derived Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CSL Limited Product Portfolio
6.4.5 CSL Limited Recent Developments/Updates

7 Plasma Derived Drugs Manufacturing Cost Analysis
7.1 Plasma Derived Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Plasma Derived Drugs
7.4 Plasma Derived Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Plasma Derived Drugs Distributors List
8.3 Plasma Derived Drugs Customers

9 Plasma Derived Drugs Market Dynamics
9.1 Plasma Derived Drugs Industry Trends
9.2 Plasma Derived Drugs Growth Drivers
9.3 Plasma Derived Drugs Market Challenges
9.4 Plasma Derived Drugs Market Restraints

10 Global Market Forecast
10.1 Plasma Derived Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Plasma Derived Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Plasma Derived Drugs by Type (2022-2027)
10.2 Plasma Derived Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Plasma Derived Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Plasma Derived Drugs by Application (2022-2027)
10.3 Plasma Derived Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Plasma Derived Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Plasma Derived Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Plasma Derived Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Plasma Derived Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Plasma Derived Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Plasma Derived Drugs Covered in This Study
Table 5. Global Plasma Derived Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Plasma Derived Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Plasma Derived Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Plasma Derived Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Plasma Derived Drugs Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Plasma Derived Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Plasma Derived Drugs Product Type
Table 12. Global Plasma Derived Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Plasma Derived Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Derived Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Plasma Derived Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Plasma Derived Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Plasma Derived Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Plasma Derived Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Plasma Derived Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Plasma Derived Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Plasma Derived Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Plasma Derived Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Plasma Derived Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Plasma Derived Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Plasma Derived Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Plasma Derived Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Plasma Derived Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Plasma Derived Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Plasma Derived Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Plasma Derived Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Plasma Derived Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Plasma Derived Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Plasma Derived Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Plasma Derived Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Plasma Derived Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Plasma Derived Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Plasma Derived Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Plasma Derived Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Plasma Derived Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Plasma Derived Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Plasma Derived Drugs Revenue Share by Type (2016-2021)
Table 42. Global Plasma Derived Drugs Price (US$/Unit) by Type (2016-2021)
Table 43. Global Plasma Derived Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Plasma Derived Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Plasma Derived Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Plasma Derived Drugs Revenue Share by Application (2016-2021)
Table 47. Global Plasma Derived Drugs Price (US$/Unit) by Application (2016-2021)
Table 48. Grifols, S.A. Corporation Information
Table 49. Grifols, S.A. Description and Business Overview
Table 50. Grifols, S.A. Plasma Derived Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Grifols, S.A. Plasma Derived Drugs Product
Table 52. Grifols, S.A. Recent Developments/Updates
Table 53. Octapharma Corporation Information
Table 54. Octapharma Description and Business Overview
Table 55. Octapharma Plasma Derived Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Octapharma Plasma Derived Drugs Product
Table 57. Octapharma Recent Developments/Updates
Table 58. Antares Pharma Corporation Information
Table 59. Antares Pharma Description and Business Overview
Table 60. Antares Pharma Plasma Derived Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Antares Pharma Plasma Derived Drugs Product
Table 62. Antares Pharma Recent Developments/Updates
Table 63. CSL Limited Corporation Information
Table 64. CSL Limited Description and Business Overview
Table 65. CSL Limited Plasma Derived Drugs Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. CSL Limited Plasma Derived Drugs Product
Table 67. CSL Limited Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Plasma Derived Drugs Distributors List
Table 71. Plasma Derived Drugs Customers List
Table 72. Plasma Derived Drugs Market Trends
Table 73. Plasma Derived Drugs Growth Drivers
Table 74. Plasma Derived Drugs Market Restraints
Table 75. Global Plasma Derived Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 76. Global Plasma Derived Drugs Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Plasma Derived Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Plasma Derived Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Plasma Derived Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 80. Global Plasma Derived Drugs Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Plasma Derived Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Plasma Derived Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Plasma Derived Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 84. Global Plasma Derived Drugs Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Plasma Derived Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Plasma Derived Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plasma Derived Drugs
Figure 2. Global Plasma Derived Drugs Market Share by Type in 2020 & 2027
Figure 3. Immunoglobulins Product Picture
Figure 4. Albumins Product Picture
Figure 5. Clotting Factors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Plasma Derived Drugs Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Speciality Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Diagnostic Centers
Figure 12. Others
Figure 13. Global Plasma Derived Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Plasma Derived Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Plasma Derived Drugs Sales 2016-2027 (K Units)
Figure 16. Global Plasma Derived Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Plasma Derived Drugs Sales Share by Manufacturers in 2020
Figure 18. Global Plasma Derived Drugs Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Plasma Derived Drugs Players: Market Share by Revenue in 2020
Figure 20. Plasma Derived Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Plasma Derived Drugs Sales Market Share by Region (2016-2021)
Figure 22. Global Plasma Derived Drugs Sales Market Share by Region in 2020
Figure 23. Global Plasma Derived Drugs Revenue Market Share by Region (2016-2021)
Figure 24. Global Plasma Derived Drugs Revenue Market Share by Region in 2020
Figure 25. U.S. Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Plasma Derived Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Plasma Derived Drugs by Type (2016-2021)
Figure 50. Sales Market Share of Plasma Derived Drugs by Application (2016-2021)
Figure 51. Sales Market Share of Plasma Derived Drugs by Application in 2020
Figure 52. Revenue Share of Plasma Derived Drugs by Application (2016-2021)
Figure 53. Revenue Share of Plasma Derived Drugs by Application in 2020
Figure 54. Manufacturing Cost Structure of Plasma Derived Drugs
Figure 55. Manufacturing Process Analysis of Plasma Derived Drugs
Figure 56. Plasma Derived Drugs Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed